PRIMAQUINE diphosphate, eq. 15mg base, tab.
STD
DORAPRIM1T-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
30/12/2025, 22:05:45
Former
Code(s):
-X
P01BA03
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
PRIMAQUINE
Therapeutic Action
Antimalarial
Indications
Radical cure (prevention of relapses) in patients with uncomplicated Plasmodium vivax or P. ovale malaria.
In low-transmission areas, reduction of the transmission in patients with P. Falciparum infection, in association with an artemisinin-based combination therapy (ATC).
Used as a gametocide for Plasmodium falciparum in the malaria elimination phase.
Instructions for use
Qualitative and semi-quantitative test (near-patient) to determine the G6PD status of patients should be available to guide the administration of primaquine.
The 2.5mg, dispersible tablet is intended for paediatric use.
Precautions for Use
Contraindicated:
- during pregnancy
- in women breastfeeding infants aged < 1 month
- in infants aged < 1 month
- in people with G6PD deficiency
Storage
Below 25ºC